BACKGROUND: The p16(INK4A) gene encodes 2 cell cycle regulator proteins, p16 and p14(ARF), by alternative splicing. This genetic locus also contains another cell cycle regulator gene, p15(INK4B), which encodes p15. The inactivation of the p16 protein has been demonstrated in some hepatocellular carcinomas (HCCs); however, the inactivation of the other 2 cell regulator proteins and their inactivation patterns are not well characterized. METHODS: To characterize the role of the above 3 cell cycle regulator proteins in HCCs, the authors examined the genomic status of the p16(INK4A) and p15(INK4B) genes and their RNA products in 20 HCC tissues and 7 human HCC cell lines. Homozygous deletions in each exon of p16(INK4A) and p15(INK4B) were e...
Cell cycle arrest at the G(1) checkpoint allows completion of critical macromolecular events prior t...
The molecular mechanisms of hepatocarcinogenesis are poorly understood. Only very recently has there...
Despite significant advances in the detection and treatment of hepatocellular carcinoma, the prognos...
One of the main regulatory pathways reported to be altered in hepatocellular carcinoma (HCC) is that...
PURPOSE: The p16(INK4A) gene encodes a specific inhibitor of cell cycle progression. In recent years...
Background/Aim: Both p16(INK4a) and p53 proteins are negative regulators of the cell cycle. In human...
Background/Aim: Both p16(INK4a) and p53 proteins are negative regulators of the cell cycle. In human...
PURPOSE: The tumor suppressor gene p16INK4A is mainly inactivated by an epigenetic change involving ...
Abstract Background The product of CDKN2A, p16 is an essential regulator of the cell cycle controlli...
CDKN2A (p16(INK4A)/MTS1) and CDKN2B (p15(INK4B)/MTS2) have recently been shown to be potent inhibito...
Background One of the most frequently deleted genes in cancer is CDKN2A encoding p16. This protein i...
Epigenetic silencing of tumour suppressor genes has been observed in various cancers. Looking at hep...
[[abstract]]Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death wo...
Hepatocellular carcinoma (HCC) frequently shows an allelic imbalance (AI) on chromosome 16q. In orde...
Chromosome 9p21, a locus comprising the tumor suppressor genes (TSG) p16(INK4) (a) and p14(ARF) , is...
Cell cycle arrest at the G(1) checkpoint allows completion of critical macromolecular events prior t...
The molecular mechanisms of hepatocarcinogenesis are poorly understood. Only very recently has there...
Despite significant advances in the detection and treatment of hepatocellular carcinoma, the prognos...
One of the main regulatory pathways reported to be altered in hepatocellular carcinoma (HCC) is that...
PURPOSE: The p16(INK4A) gene encodes a specific inhibitor of cell cycle progression. In recent years...
Background/Aim: Both p16(INK4a) and p53 proteins are negative regulators of the cell cycle. In human...
Background/Aim: Both p16(INK4a) and p53 proteins are negative regulators of the cell cycle. In human...
PURPOSE: The tumor suppressor gene p16INK4A is mainly inactivated by an epigenetic change involving ...
Abstract Background The product of CDKN2A, p16 is an essential regulator of the cell cycle controlli...
CDKN2A (p16(INK4A)/MTS1) and CDKN2B (p15(INK4B)/MTS2) have recently been shown to be potent inhibito...
Background One of the most frequently deleted genes in cancer is CDKN2A encoding p16. This protein i...
Epigenetic silencing of tumour suppressor genes has been observed in various cancers. Looking at hep...
[[abstract]]Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death wo...
Hepatocellular carcinoma (HCC) frequently shows an allelic imbalance (AI) on chromosome 16q. In orde...
Chromosome 9p21, a locus comprising the tumor suppressor genes (TSG) p16(INK4) (a) and p14(ARF) , is...
Cell cycle arrest at the G(1) checkpoint allows completion of critical macromolecular events prior t...
The molecular mechanisms of hepatocarcinogenesis are poorly understood. Only very recently has there...
Despite significant advances in the detection and treatment of hepatocellular carcinoma, the prognos...